Sativex - Page 2 of 7

Study: Cannabinoids Can Treat Symptoms of Multiple Sclerosis Better Than Pharmaceutical Alternatives

Posted on 03/02/2014 by Web Team | 0 Comments

A study published in the journal Expert Review of Neurotherapeutics, and published online by the National Institute of Health, has found promising evidence that cannabinoids can provide a natural treatment…

GW Pharmaceuticals plc Announces US Patent Allowance for Use of Cannabinoids in Treating Glioma

Posted on 11/12/2013 by Web Team | 0 Comments

GW Pharmaceuticals a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that the United States Patent and Trademark Office (USPTO) has…

Switzerland Approves Cannabis Derived Sativex As Prescription Medicine

Posted on 29/11/2013 by Web Team | 0 Comments

London, UK, 27 November 2013: GW Pharmaceuticals a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that it has received regulatory…

GW Pharmaceuticals Announces Successful Closing of Mutual Recognition Procedure for Sativex in France

Posted on 28/10/2013 by Web Team | 0 Comments

London, UK; 21 October 2013: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, “GW” or the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary…

FDA Approves Investigational Trials Assessing Cannabidiol For Pediatric Epilepsy

Posted on 28/10/2013 by Web Team | 0 Comments

Washington, DC: The US Food and Drug Administration has approved two clinical trials to assess the efficacy of cannabidiol (CBD), a nonpsychoactive plant cannabinoid, in the treatment of intractable pediatric…

Medical cannabis demonstration at parliament highlights hypocrisy of British laws

Posted on 12/10/2013 by Web Team | 0 Comments

National cannabis law reform organisation, NORML UK held a medical cannabis demonstration on College Green by the Houses of Parliament on the 9th October 2013. A Dutch medical patient who…

New data reinforces the efficacy and safety profile of cannabis in Multiple Sclerosis Spasticity

Posted on 09/10/2013 by Web Team | 0 Comments

London, UK; 2 October 2013: GW Pharmaceuticals plc (AIM: GWP, Nasdaq: GWPH, “GW”) announced that data from new MS spasticity studies (clinical trial data, observational study data and registries data…

Cannabis to be consumed legally in public near Parliament

Posted on 05/10/2013 by Web Team | 0 Comments

NORML UK, the national organisation for cannabis law reform, will be holding a static demonstration close to the Houses of Parliament on Wednesday 9th October 2013, commencing around midday. The…

Study Confirms Cannabis Has No Long-Term Negative Effect on Cognition

Posted on 05/08/2013 by Web Team | 0 Comments

London, UK, 5 August 2013: GW Pharmaceuticals plc (NASDAQ: GWPH, AIM: GWP, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from…

Marijuana-Based Medicines Okayed in France

Posted on 12/06/2013 by Web Team | 0 Comments

At the behest of Social Affairs and Health Minister Marisol Touraine, France has modified its Public Health Code to allow for the use of marijuana-based medicines, apparently including raw marijuana…